Trial intelligence / Profile preview

Drug-drug Interactions of Atorvastatin and Telmisartan in Healthy Volunteers

NCT07784608Phase 1Not yet recruiting

Sponsor
Huons
Start
Sep 2026
Primary completion
Apr 2027
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of atorvastatin and telmisartan in hypercholesterolemia and hypertension (HTN), sponsored by Huons. Primary endpoints: Area Under the Concentration-Time Curve Over the Dosing Interval at Day 22 and Maximum Steady-State Plasma Concentration at Day 22. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

atorvastatintelmisartan
03

Conditions

hypercholesterolemiahypertension (HTN)

Beyond the preview

Go deeper on NCT07784608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07784608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call